Copyright: ©Author(s) 2026.
World J Clin Oncol. Apr 24, 2026; 17(4): 115287
Published online Apr 24, 2026. doi: 10.5306/wjco.v17.i4.115287
Published online Apr 24, 2026. doi: 10.5306/wjco.v17.i4.115287
Figure 1 Changes in microRNA expression across tumor grades before and after neoadjuvant chemotherapy.
Sankey diagram illustrating the relative distribution of normalized expression levels of selected microRNAs across tumor grades (G1, G2, G3) in primary tumors (left) and post-neoadjuvant chemotherapy tumors (right). NACT: Neoadjuvant chemotherapy.
- Citation: Ryspayeva D, Seyhan AA, Mu K, Liu M, Purcell C, MacDonald WJ, Halytskiy V, Drevytska T, Inomistova M, Khranovska N, Potorocha O, Taran L, Sumkina O, Smolanka Sr I, El-Deiry WS. Longitudinal microRNA profiles in breast cancer tissue and plasma: Associations with hormone receptors, response, and survival. World J Clin Oncol 2026; 17(4): 115287
- URL: https://www.wjgnet.com/2218-4333/full/v17/i4/115287.htm
- DOI: https://dx.doi.org/10.5306/wjco.v17.i4.115287